Qualys Guides Higher, but 41% Overvaluation Risk Is Hard to Ignore

Qualys execution improved, but the stock may have repriced too quickly

Qualys now looks more like a quality execution story than a distressed one. But the rerating may already be too far, too fast. After the company updated its FY 2026 earnings guidance on Tuesday morning, the stock traded up $6.17 during midday trading

What improved in the quarter

Qualys posted Q2 revenue of $182.2 million, up 11% year on year. Non-GAAP EPS reached $1.98, above expectations, and Adjusted EBITDA margin was 46%. Management also raised its FY 2026 earnings and revenue outlook, lifting full-year revenue guidance to $732 million to $738 million and EPS guidance to $7.74 to $7.88.

That is strong execution, not a repair attempt. The question is whether the market has already discounted most of that improvement.

The bull case and the caution sign

The bull case is straightforward: Qualys is delivering above-consensus revenue, earnings, and guidance at the same time. That supports the idea that demand is holding up and the business is executing better than feared.

The caution sign is valuation and expectations. Even after the guidance raise, analyst sentiment remains cautious, with a consensus rating of "Hold" and an average price target of $142.53. The stock was also hitting $161.06 during the session, not far from its 12 month high of $167.86. That leaves less room for a merely solid follow-through quarter.

Why a guidance raise can still trigger an overreaction

Qualys delivered several positive signals at once: billings grew 18.1% to $176.5 million, Operating Margin was 34%, up from 31.3%, and management raised its full-year outlook. That kind of package can pull in momentum buyers before investors fully separate business improvement from stock attractiveness.

Recent price strength can also shape perception. When a stock has already rallied on improving sentiment, a new guidance raise can feel like confirmation that the old base case was too low, even if the better reading is simply that the business is stabilizing rather than entering a new phase of exceptional growth.

Better operations do not automatically mean a richer multiple

Company quality and stock attractiveness are different questions. Qualys clearly improved operationally. The key issue is whether the market is now paying for progress that was partly already expected.

At a market cap of $5.67 billion versus a raised full-year revenue range of $732 million to $738 million, the business is trading at roughly 5.3x forward sales. That is a rich base for a company that still has to prove growth reacceleration can persist beyond one quarter.

The Street's stance offers a useful reality check: analyst sentiment remains cautious, with a consensus rating of "Hold" and an average price target of $142.53. That does not mean Qualys is a bad business. It suggests investors may view it as a better operator rather than a clear candidate for another multiple expansion.

When the current valuation can still work

The bullish case is not baseless. Qualys posted Q2 Revenue Growth of 11% Year-Over-Year, maintained a 46% margin in adjusted EBITDA, and management highlighted growing AI-native Risk Operations Center adoption, a growing federal pipeline, and partner-led execution.

If those drivers continue to compound, today's valuation can be justified over time. But that usually requires another round of guidance raises or consistently strong execution against the new bar, not just one good quarter.

What the next quarter needs to prove

The next report should clarify whether the guidance raise started a new leg higher or marked the peak of the relief move.

Near-term proof points

Management has set Q3 2026 EPS guidance was set at $1.91 to $1.98 and a Guidance for next quarter's revenue was optimistic at $186.5 million at the midpoint. That makes the next checkpoint more explicit.

Watch for: - Another guidance raise, not just a hold, against the updated Q3 framework. - Revenue above the $186.5 million Q3 midpoint. - EPS at the top end of, or above, $1.91 to $1.98. - Billings that remain healthy relative to revenue. - Margin quality near the recent 46% margin in adjusted EBITDA.

What would weaken the overvaluation call

If those checkpoints clear, the stock can remain rich and still be justified. The overvaluation view weakens when execution keeps outrunning expectations.

The opposite is also true: if Qualys merely meets the new bar, holds full-year guidance, and the stock stalls near recent highs, valuation is likely to matter more again. Given that analyst sentiment remains cautious, with a consensus rating of "Hold" and an average price target of $142.53, a quarter that is only solid rather than strong may not be enough to sustain the latest rerating.